CN109503500A - A kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid - Google Patents

A kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid Download PDF

Info

Publication number
CN109503500A
CN109503500A CN201811539865.XA CN201811539865A CN109503500A CN 109503500 A CN109503500 A CN 109503500A CN 201811539865 A CN201811539865 A CN 201811539865A CN 109503500 A CN109503500 A CN 109503500A
Authority
CN
China
Prior art keywords
oxopyrazine
acetic acid
reaction
tert
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811539865.XA
Other languages
Chinese (zh)
Inventor
林琦森
甄蕊
张静波
刘小丽
柴艳萍
朱喜雯
吴璇
刘颖
哈维杰
李磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuxi Apptec Tianjin Co Ltd
Original Assignee
Wuxi Apptec Tianjin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuxi Apptec Tianjin Co Ltd filed Critical Wuxi Apptec Tianjin Co Ltd
Priority to CN201811539865.XA priority Critical patent/CN109503500A/en
Publication of CN109503500A publication Critical patent/CN109503500A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention relates to the synthetic methods of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid.There is no the technical issues of industrializing synthesis route before mainly solving this compound.A kind of technical solution of the present invention: synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid, the following steps are included: the first step, 2- Oxopyrazine is dissolved in nitrogen, in nitrogen-dimethyl acetamide, then potassium carbonate is added, is eventually adding 2- bromo-acetic acid tert-butyl.2- (2- Oxopyrazine -1 (2H)-yl) tert-butyl acetate is obtained after the reaction was completed.Second step, 2- (2- Oxopyrazine -1 (2H)-yl) tert-butyl acetate is dissolved in methylene chloride, then hydrochloric acid/dioxane solution is added, it is post-treated to obtain 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid after reaction is completed.Present invention employs raw materials cheap and easy to get, avoid complicated last handling process, only obtain target molecule by two-step reaction, be easy to amplify.

Description

A kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid
Technical field
The present invention relates to a kind of practicability synthetic methods of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid.
Background technique
2- (2- Oxopyrazine -1 (2H)-yl) acetic acid, CAS 42352-55-6, synthetic route, only did milligram grade at present Reaction, taken a sample and done spectral characterization, it cannot be guaranteed that taking target compound with stable yield.
Summary of the invention
The purpose of the present invention is developing a kind of simple, general 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid synthetic method, The technical issues of mainly solving currently without Industrialized synthesis method.
Technical solution of the present invention: a kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid, including following step It is rapid:
2- Oxopyrazine is dissolved in nitrogen, in nitrogen-dimethyl acetamide, potassium carbonate is then added, is eventually adding 2- bromine by the first step Tert-butyl acetate.2- (2- Oxopyrazine -1 (2H)-yl) tert-butyl acetate is obtained after the reaction was completed.
2- (2- Oxopyrazine -1 (2H)-yl) tert-butyl acetate is dissolved in methylene chloride, salt is then added by second step Acid/dioxane solution, it is post-treated to obtain 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid after reaction is completed.Reaction equation is such as Under:
First step reaction temperature be room temperature, the reaction time 7 hours;Second step reaction temperature is room temperature, is reacted 16 hours.
Beneficial effects of the present invention: rationally, step is simple for reaction process of the present invention design, use it is cheap and easy to get, can advise The raw material of modelling production avoids complicated last handling process, only obtains target molecule by two-step reaction, be easy to be enlarged into industry It is combined to, has filled up the synthesis blank of 2- (2- Oxopyrazine -1 (2H)-yl) commercial acetic acid.
Specific embodiment
The synthesis of 2- (2- Oxopyrazine -1 (2H)-yl) tert-butyl acetate
10 g of compound 1 are added in the round-bottomed flask of 1L, are added the nitrogen of 300mL, nitrogen-dimethyl acetamide dissolution, then plus Enter 17 grams of potassium carbonate, be eventually adding 24 g of compound 2,7 hours are stirred at room temperature in reaction solution.
It is completed to reaction detection, the dilution of 900mL ethyl acetate is added in filtering removal potassium carbonate, respectively with 300mL water extraction two Secondary, organic phase is washed twice with saturated salt solution 300mL, and organic phase is dry by anhydrous sodium sulfate, is concentrated by Rotary Evaporators Obtain crude product.Crude product passes through silica gel column purification, obtains 18.3 g of compound 3, yield 83%.
1H NMR (400MHz, DMSO-d6) Shift = 8.057 (s, 1H), 7.645-7.634 (d, J= 4.4 Hz, 1H), 7.371-7.360 (d. J= 4.4 Hz, 1H), 4.617 (s, 2H), 1.426 (S, 9H)。
The synthesis of the synthesis of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid
6 g of compound 3 are added to 250mL round-bottomed flask, the dissolution of 50mL methylene chloride is added, 4M hydrochloric acid/dioxy is then added Six ring 21mL, are stirred at room temperature, and react 16 hours.The precipitating of precipitation is collected by filtration, and methylene chloride washing obtains 4 after dry G of compound 4, yield 92%.
1H NMR (400MHz, DMSO-d6) Shift = 8.173-8.157 (m, 1H), 7.695-7.666 (m, 1H), 7.459-7.441 (m, 1H), 4.761-4.755 (m, 2H)。

Claims (3)

1. a kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid, it is characterized in that: the following steps are included: the first step, 2- Oxopyrazine is dissolved in nitrogen, in nitrogen-dimethyl acetamide, potassium carbonate is then added, is eventually adding 2- bromo-acetic acid tert-butyl, 2- (2- Oxopyrazine -1 (2H)-yl) tert-butyl acetate is obtained after the reaction was completed;Second step, by 2- (2- Oxopyrazine -1 (2H) - Base) tert-butyl acetate is dissolved in methylene chloride, hydrochloric acid/dioxane solution is then added, after reaction is completed, post-treated To 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid;Reaction equation is as follows:
2. a kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid according to claim 1, it is characterized in that: First step reaction temperature be room temperature, the reaction time 7 hours.
3. a kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid according to claim 1, it is characterized in that: Second step reaction temperature be room temperature, the reaction time 16 hours.
CN201811539865.XA 2018-12-17 2018-12-17 A kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid Pending CN109503500A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811539865.XA CN109503500A (en) 2018-12-17 2018-12-17 A kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811539865.XA CN109503500A (en) 2018-12-17 2018-12-17 A kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid

Publications (1)

Publication Number Publication Date
CN109503500A true CN109503500A (en) 2019-03-22

Family

ID=65753479

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811539865.XA Pending CN109503500A (en) 2018-12-17 2018-12-17 A kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid

Country Status (1)

Country Link
CN (1) CN109503500A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009123870A1 (en) * 2008-04-04 2009-10-08 Merck & Co., Inc. Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
CN102391255A (en) * 2008-04-04 2012-03-28 默沙东公司 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009123870A1 (en) * 2008-04-04 2009-10-08 Merck & Co., Inc. Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
CN102391255A (en) * 2008-04-04 2012-03-28 默沙东公司 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists

Similar Documents

Publication Publication Date Title
CN105622535B (en) A kind of preparation method of LCZ696
JP6948419B2 (en) New manufacturing method for chromanon derivatives
CN105814020A (en) Substituted nicotinamide derivatives as kinase inhibitors
CN105175401A (en) Preparation method of brexpiprazole
CN106256824B (en) Preparation method of high-purity delafloxacin meglumine salt
CN103772278A (en) Important tetrahydroisoquinoline derivative midbody and synthesis method thereof
TWI703163B (en) Method for preparing sugammadex sodium and crystalline form thereof
CN110872262A (en) Synthesis method of cariprazine
JP2007503476A (en) Improved production of rebamipide
CN109867673B (en) Method for synthesizing palbociclib
CN109503500A (en) A kind of synthetic method of 2- (2- Oxopyrazine -1 (2H)-yl) acetic acid
CN103665084A (en) Method for preparing abiraterone acetate
CN106892803B (en) Preparation method of 2, 6-dichloro-3-fluorobenzaldehyde and preparation method of fluoroquinolone compound
CN107176906A (en) A kind of synthetic method of substitution indone
CN111349045A (en) Synthetic method of lenvatinib and novel intermediate
CN112645880B (en) Synthetic method of enzalutamide
CN105085595B (en) A kind of method of deacylation base protection 2,6 halosubstituted purine nucleosides of synthesis
CN110903211B (en) Preparation method of L-theanine
CN111269094B (en) Preparation method of 2-bromo-1, 3-dimethoxybenzene
CN106045995A (en) Synthesizing method of 5-bromine-1H-pyrrolo[2,3-b]pyridine
CN112125790A (en) Synthesis method of 7-chloro-1-naphthaldehyde
JP5501054B2 (en) Method for producing 3,3-diaminoacrylic acid (1-diphenylmethylazetidin-3-yl) ester acetate
CN103880730A (en) Chemical synthesis method of 7-nitroindole-3-tert butyl formate
CN107353275B (en) Synthesis method of xanthene-9-formic acid
CN103450182B (en) Preparation and purification methods of Retapamulin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190322